Lndip 5mg Tablet contains Cilnidipine, a calcium channel blocker primarily used in the management of hypertension. By inhibiting the influx of calcium ions through L-type and N-type calcium channels in vascular smooth muscle and sympathetic nerve endings, Cilnidipine induces vasodilation, thereby reducing peripheral vascular resistance and lowering blood pressure. This dual mechanism not only decreases arterial pressure but also modulates sympathetic nerve activity, contributing to improved cardiovascular outcomes. Lndip 5mg is indicated for the treatment of essential hypertension and may be used as monotherapy or in combination with other antihypertensive agents to achieve optimal blood pressure control. The tablet is generally well tolerated; common adverse effects include headache, dizziness, flushing, and peripheral edema. It is contraindicated in patients with known hypersensitivity to Cilnidipine or other dihydropyridine derivatives. Caution is advised in individuals with severe hepatic impairment or heart failure. Regular monitoring of blood pressure and renal function is recommended during therapy. Lndip 5mg should be administered as prescribed by a healthcare professional, with dosage adjustments based on therapeutic response and tolerability. This medication contributes significantly to the management of hypertension, thereby reducing the risk of cardiovascular morbidity and mortality.